February 24, 2020

MRNA Stock Surges 18% In After-hours On Coronavirus Trial

MRNA stock surged 18% higher in after-hours trading on February 24, 2020, after the company announced that it has released the first batch of mRNA-1273, the Company’s vaccine against the

by Lance Jepsen

Biotechnology

Stock Trading

February 24, 2020

COCP Stock Surges More Than 60% On Coronavirus

COCP stock closed up more than 60% on February 24, 2020, after the company announced a license agreement for antiviral compounds. COCRYSTAL PHARMA, a clinical stage biotechnology company discovering and developing

by Lance Jepsen

Biotechnology

Stock Trading

February 24, 2020

ENLV Stock Moving On Coronavirus In Israel

ENLV stock is churning in pre-market trading on February 24, 2020. Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today announced that it is initiating a plan to increase its

February 23, 2020

Bullish Options Flow Detected In GILD Stock

Bullish options flow was detected in GILD stock on February 21, 2020. 92,710 calls were traded, 3x expected, and implied vol increased more than 4 points to over 32.5%. 2/28

by Lance Jepsen

Biotechnology

Stock Trading

February 18, 2020

GNPX Stock Still Moving On Cure For Diabetes

GNPX stock is still attracting buyers after the company announced an exclusive deal with the University of Pittsburgh on February 11, 2020. The pancreas is an extremely difficult organ to deal

by Lance Jepsen

Biotechnology

Stock Trading

February 15, 2020

EPZM Stock Up On FDA Accelerated Approval of TAZVERIK

EPZM stock closed higher on February 14, 2020, after the company announced that the FDA accepted its application for accelerated approval of TAZVERIK. Epizyme, Inc. (Nasdaq: EPZM), a fully integrated commercial-stage

by Lance Jepsen

Biotechnology

Stock Trading

February 13, 2020

GNPX Stock Higher On Possible Cure For Diabetes

GNPX stock is trending higher after news on February 11, 2020, about a potential cure for Diabetes Type 1 and Type 2. As a reminder, on February 11, 2020, Genprex, Inc.

by Lance Jepsen

Biotechnology

Stock Trading

February 13, 2020

INO Stock Moving After Company Says They Have Coronavirus Vaccine

INO stock is moving higher on February 13, 2020, after the company announced that it has a vaccine for the coronavirus. Fox Business reports that Inovio Pharmaceuticals (INO) says that it

by Lance Jepsen

Biotechnology

Stock Trading

February 12, 2020

Coronavirus Stocks Moved In After-hours Trade On Feb 12 2020

Coronavirus stocks were on the move in after-hours trading on February 12, 2020. 5 Coronavirus Stocks With Explosive Potential APT Stock was up more than 17% in after-hours trade on February 12,

by Lance Jepsen

Penny Stocks

Stock Trading

February 12, 2020

AIM ImmunoTechs CEO to Appear Live Today on FOX Business Networks The Claman Countdown to Discuss the Role of Ampligen for Use Against the Coronavirus

IM ImmunoTech Inc. (NYSE American:AIM), an immuno-pharma business lazer focused on the research and development of therapeutics to treat immune disorders, viral diseases and a number of kinds of cancers,

by Lance Jepsen

« Older Articles

Biotechnology

MRNA Stock Surges 18% In After-hours On Coronavirus Trial

COCP Stock Surges More Than 60% On Coronavirus

ENLV Stock Moving On Coronavirus In Israel

Bullish Options Flow Detected In GILD Stock

GNPX Stock Still Moving On Cure For Diabetes

EPZM Stock Up On FDA Accelerated Approval of TAZVERIK

GNPX Stock Higher On Possible Cure For Diabetes

INO Stock Moving After Company Says They Have Coronavirus Vaccine

Coronavirus Stocks Moved In After-hours Trade On Feb 12 2020

AIM ImmunoTechs CEO to Appear Live Today on FOX Business Networks The Claman Countdown to Discuss the Role of Ampligen for Use Against the Coronavirus

Shocking Leaked Video Footage From Coronavirus Outbreak Epicenter!

Shocking Coronavirus Handling In California, CDCs Unprofessionalism Revealed

Stop Limit Order Your Way To Massive Profits

TTNP Stock Attracting Buyers After VA Contract

AIM ImmunoTechs CEO to Appear Live Today on FOX Business Networks The Claman Countdown to Discuss the Role of Ampligen for Use Against the Coronavirus

MRNA Stock Surges 18% In After-hours On Coronavirus Trial